Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors

Clinical trial NCT04007744 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04007744
Sponsor: Mayo Clinic
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical Stage III Cutaneous Melanoma AJCC v8 Clinical Stage III Gastric Cancer AJCC v8 Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IV Cutaneous Melanoma AJCC v8 Clinical Stage IV Gastric Cancer AJCC v8 Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 Locally Advanced Gastric Adenocarcinoma Locally Advanced Gastroesophageal Junction Adenocarcinoma Locally Advanced Urothelial Carcinoma Metastatic Gastric Adenocarcinoma Metastatic Gastroesophageal Junction Adenocarcinoma Metastatic Head and Neck Squamous Cell Carcinoma

Start date: 2020-02-13
Primary completion: 2025-05-08
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.